Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groups

Prognostic models have been proposed to predict survival for non-small-cell lung cancer (NSCLC). It is important to evaluate whether these models perform better than performance status (PS) alone in stage- and age-specific subgroups.